Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,452 | 371 | 93.9% |
| Education | $352.25 | 5 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $975.20 | 60 | $0 (2024) |
| ABBVIE INC. | $916.17 | 70 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $488.30 | 36 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $465.21 | 25 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $437.80 | 16 | $0 (2024) |
| Dermavant Sciences, Inc. | $403.31 | 33 | $0 (2024) |
| GENZYME CORPORATION | $396.63 | 20 | $0 (2024) |
| PFIZER INC. | $374.45 | 36 | $0 (2024) |
| Janssen Biotech, Inc. | $366.22 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $355.30 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,895 | 163 | Verrica Pharmaceuticals Inc. ($406.20) |
| 2023 | $1,430 | 105 | Incyte Corporation ($296.00) |
| 2022 | $1,004 | 75 | Incyte Corporation ($345.57) |
| 2021 | $475.36 | 33 | AbbVie Inc. ($83.16) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.80 | General |
| Category: Immunology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $124.62 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.30 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.60 | General |
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Immunology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $10.61 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $4.52 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 249 | 356 | $52,344 | $20,118 |
| 2022 | 5 | 195 | 270 | $43,785 | $19,176 |
| 2021 | 8 | 322 | 425 | $61,720 | $27,297 |
| 2020 | 3 | 128 | 165 | $33,375 | $10,737 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 166 | $24,080 | $9,354 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $11,050 | $4,643 | 42.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 37 | 42 | $8,400 | $2,911 | 34.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 19 | $3,160 | $1,318 | 41.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 14 | $2,450 | $1,125 | 45.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 14 | 21 | $3,150 | $745.50 | 23.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 27 | $54.00 | $21.37 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 131 | $18,985 | $8,007 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 65 | 65 | $9,475 | $4,703 | 49.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 37 | 40 | $8,000 | $2,879 | 36.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 14 | 19 | $4,750 | $2,267 | 47.7% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 12 | 15 | $2,575 | $1,320 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 92 | 153 | $21,525 | $9,659 | 44.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 97 | 97 | $13,450 | $7,347 | 54.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 62 | 68 | $13,600 | $5,071 | 37.3% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 12 | 23 | $5,750 | $2,930 | 50.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 13 | 21 | $3,150 | $858.98 | 27.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 18 | 21 | $2,100 | $858.04 | 40.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 15 | $1,875 | $548.34 | 29.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 15 | 27 | $270.00 | $26.18 | 9.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 77 | $13,750 | $4,245 | 30.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 54 | 54 | $9,375 | $3,878 | 41.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 27 | 34 | $10,250 | $2,615 | 25.5% |
About Elisheva Miller, PHYSICIAN ASSISTANT
Elisheva Miller, PHYSICIAN ASSISTANT is a Physician Assistant healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669409348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Elisheva Miller, PHYSICIAN ASSISTANT has received a total of $5,804 in payments from pharmaceutical and medical device companies, with $2,895 received in 2024. These payments were reported across 376 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,452).
As a Medicare-enrolled provider, Miller has provided services to 894 Medicare beneficiaries, totaling 1,216 services with total Medicare billing of $77,328. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Brooklyn, NY
- Active Since 06/27/2006
- Last Updated 01/31/2011
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1669409348
Products in Payments
- OPZELURA (Drug) $890.20
- RINVOQ (Biological) $504.08
- DUPIXENT (Biological) $476.62
- YCANTH (Drug) $437.80
- VTAMA (Drug) $403.31
- SKYRIZI (Biological) $384.35
- EUCRISA (Drug) $359.18
- Sotyktu (Drug) $355.30
- TREMFYA (Drug) $351.09
- ILUMYA (Biological) $305.89
- COSENTYX (Drug) $284.21
- COSENTYX (Biological) $131.69
- Cimzia (Drug) $129.04
- JUBLIA (Drug) $85.96
- Ilumya (Biological) $57.34
- ADBRY (Biological) $45.95
- AMELUZ (Drug) $43.75
- TALTZ (Drug) $33.03
- Winlevi (Drug) $29.98
- Cabtreo (Drug) $15.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Brooklyn
Kaitlyn Nelson, Pa-C, PA-C
Physician Assistant — Payments: $262,844
Steven Kong
Physician Assistant — Payments: $55,299
Mrs. Melissa Velez, Rpa-C, RPA-C
Physician Assistant — Payments: $53,018
Hong Chen
Physician Assistant — Payments: $47,002
Gregory Celestin, Pa, PA
Physician Assistant — Payments: $30,181
Lindsey Axt, Pa-C, PA-C
Physician Assistant — Payments: $26,935